Cellectis (CLLS) Gross Profit (2015 - 2023)
Cellectis (CLLS) recorded quarterly Gross Profit of $116000.0 in Q4 2023, up 546.15% quarter-over-quarter from -$26000.0 in Q3 2023, and up 176.19% on a YoY basis from $42000.0 in Q4 2022.
Cellectis (CLLS) Gross Profit (2015 - 2023) Analysis & Trends
Cellectis' Gross Profit history runs 9 years deep, the most recent figure standing at $116000.0 for Q4 2023.
- In Q4 2023, Gross Profit rose 176.19% year-over-year to $116000.0; the TTM figure through Dec 2023 stood at $18000.0 (down 97.91% YoY), while the FY2025 annual figure was $72.9 million, up 48.22% from the prior year.
- Gross Profit was $116000.0 for Q4 2023 at Cellectis, up from -$26000.0 in the prior quarter.
- In the past five years, Gross Profit ranged from a high of $45.5 million in Q1 2020 to a low of -$3.0 million in Q4 2020.
- Historically, Gross Profit has averaged $1.9 million across 5 years, with a median of -$43500.0 in 2021.
- The sharpest annual moves came in 2019 and 2020: Gross Profit soared 11034.21% in 2019, then sank 968.55% in 2020.
- A 5-year view of Gross Profit shows it stood at -$1.2 million in 2019, then sank by 145.08% to -$3.0 million in 2020, then jumped by 97.97% to -$61000.0 in 2021, then jumped by 168.85% to $42000.0 in 2022, then surged by 176.19% to $116000.0 in 2023.
- The last three Gross Profit figures came in at $116000.0 (Q4 2023), -$26000.0 (Q3 2023), and $123000.0 (Q2 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Cellectis | 17.40 Bn | 17.21 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 116,000.00 |
| Dec 31, 2023 | 116,000.00 |
| Sep 30, 2023 | -26,000.00 |
| Sep 30, 2023 | -26,000.00 |
| Jun 30, 2023 | 123,000.00 |
| Jun 30, 2023 | 123,000.00 |
| Mar 31, 2023 | -195,000.00 |
| Mar 31, 2023 | -195,000.00 |
| Dec 31, 2022 | 42,000.00 |
| Dec 31, 2022 | 42,000.00 |
| Sep 30, 2022 | -192,000.00 |
| Sep 30, 2022 | -192,000.00 |
| Jun 30, 2022 | 978,000.00 |
| Jun 30, 2022 | 978,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Mar 31, 2022 | 32,000.00 |
| Dec 31, 2021 | -61,000.00 |
| Dec 31, 2021 | -61,000.00 |
| Sep 30, 2021 | -901,000.00 |
| Sep 30, 2021 | -901,000.00 |